Skip to main content
Terug
Watch Compare

RxSight, Inc.

Datakwaliteit: 100%
RXST
NASDAQ Manufacturing Measuring & Analyzing Instruments
€ 6,83
▲ € 0,06 (0,89%)
Marktkapitalisatie: 279,37 M
Prijs
€ 6,77
Marktkapitalisatie
279,37 M
Dagbereik
—
52-Weeksbereik
—
Volume
—
Openen —
50D / 200D Gem.
—
50D / 200D Gem.
—

Quick Summary

Belangrijkste Punten

Revenue grew 56,20% annually over 5 years — strong growth
Negative free cash flow of -19,34 M
Revenue growth is decelerating — 1Y growth trails 5Y average by 60,09%
Capital efficient — spends only 2,85% of revenue on capex

Groei

Revenue Growth (5Y)
56,20%
Boven sectorgemiddelde (1,92%)
Revenue (1Y)-3,89%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
-14,06%
Boven sectorgemiddelde (-54,44%)
ROIC-13,25%
Net Margin-28,96%
Op. Margin-35,84%

Veiligheid

Debt / Equity
N/A
Current Ratio12,74
Interest Coverage-2536,37

Waardering

PE (TTM|NTM)
-7,17 | -14,16
Onder sectorgemiddelde (-1,49)
P/B Ratio1,01
EV/EBITDAN/A
Dividend YieldN/A

Koershistorie

Financiële Trends

Sectorvergelijking

vs Manufacturing sector mediaan (1385 peers)
Metriek Aandeel Sector Mediaan
P/E -7,2 -1,5
P/B 1,0 1,6
ROE % -14,1 -54,4
Net Margin % -29,0 -41,5
Rev Growth 5Y % 56,2 1,9
D/E — 0,3

Koersdoel Analisten

7 analisten
Hold
Huidig
€ 6,83
+49.6%
Koersdoel
€ 10,21
€ 8,00
€ 10,00
€ 13,00
Vooruitzicht
Forward K/W -14,16
Forward WPA -€ 0,48
Omzet Sch. 143,89 M

Winstschattingen

Periode WPA Sch. Omzet Sch. Analisten
FY2027 -€ 0,48
-€ 0,64 – -€ 0,24
 143,89 M 4
FY2026 -€ 0,65
-€ 0,79 – -€ 0,55
 131,01 M 4

Winstverassingen

Laatste 4 kwartalen
Kwartaal Geschat WPA Werkelijk WPA Verrassing
Q42025 -€ 0,20 -€ 0,03 +84,8%
Q32025 -€ 0,26 -€ 0,04 +84,6%
Q22025 -€ 0,11 -€ 0,08 +29,2%
Q12025 -€ 0,08 -€ 0,03 +62,5%

ETFs Holding This Stock

FFOX FFOX
0,63% weight
GSTOX GSTOX
0,14% weight
GSROX GSROX
0,14% weight
GSZPX GSZPX
0,14% weight
GSCOX GSCOX
0,14% weight
GINUX GINUX
0,14% weight
GSIOX GSIOX
0,14% weight
IPSSX IPSSX
0,06% weight
IPSIX IPSIX
0,06% weight
GTTUX GTTUX
0,03% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) -3,89% Revenue Growth (3Y) 22,87%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 56,20% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 134,48 M Net Income (TTM) -38,94 M
ROE -14,06% ROA -12,61%
Gross Margin 76,60% Operating Margin -35,84%
Net Margin -28,96% Free Cash Flow (TTM) -19,34 M
ROIC -13,25% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 12,74
Interest Coverage -2536,37 Asset Turnover 0,44
Working Capital 261,59 M Tangible Book Value 275,97 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -7,17 Forward P/E -14,16
P/B Ratio 1,01 P/S Ratio 2,08
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S 1,94 Fwd Earnings Yield N/A
FCF Yield -6,92%
Market Cap 279,37 M Enterprise Value 249,74 M
Per Share
EPS (Diluted TTM) -0,95 Revenue / Share 3,26
FCF / Share -0,47 OCF / Share -0,38
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 2,85% FCF Conversion 49,66%
SBC-Adj. FCF -49,69 M Growth Momentum -60,09

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 134,48 M 139,93 M 89,08 M 49,01 M 22,59 M
Net Income -38,94 M -27,46 M -48,61 M -66,76 M -48,69 M
EPS (Diluted) -0,95 -0,71 -1,41 -2,41 -3,57
Gross Profit 103,01 M 98,94 M 53,77 M 21,33 M 4,52 M
Operating Income -48,19 M -36,86 M -50,09 M -63,32 M -52,79 M
EBITDA — — — — —
R&D Expenses 38,55 M 34,37 M 29,05 M 25,98 M 24,50 M
SG&A Expenses 112,65 M 101,43 M 74,80 M 58,67 M 32,81 M
D&A 3,27 M 3,58 M 4,08 M 3,88 M 3,98 M
Interest Expense 19.000,0 21.000,0 3,31 M 4,95 M 3,68 M
Income Tax 66.000,0 50.000,0 20.000,0 9.000,0 8.000,0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 311,81 M 318,56 M 182,55 M 150,16 M 192,72 M
Total Liabilities 36,13 M 37,33 M 22,19 M 60,26 M 54,48 M
Shareholders' Equity 275,68 M 281,24 M 160,36 M 89,90 M 138,24 M
Total Debt — — 0,0 40,17 M 39,76 M
Cash & Equivalents 19,95 M 16,71 M 9,69 M 11,83 M 24,36 M
Current Assets 287,46 M 293,82 M 168,41 M 134,56 M 176,30 M
Current Liabilities 26,25 M 25,88 M 20,90 M 17,24 M 11,08 M